Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Description

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Conditions

Transgender Women, Aids, Hiv

Talk to us

Study Overview

On this page

Study Details

Study overview

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Condition
Transgender Women
Intervention / Treatment

-

Contacts and Locations

Orlando

University of Central Florida, Orlando, Florida, United States, 32827

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged ≥18 years
  • * Male at birth
  • * Identify as a woman/transgender woman
  • * Should not be consistently using PrEP (less than four doses per week)
  • * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program
  • * Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write)
  • * Have a smart phone that can take pictures
  • * Unwilling to adhere to study procedures
  • * Participation in an HIV vaccine trial
  • * Have a life-threatening SUD\*
  • * Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP
  • * Unable to provide consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Central Florida,

Elena Cyrus, PhD, PRINCIPAL_INVESTIGATOR, University of Central Florida

Study Record Dates

2027-06